BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23618692)

  • 1. Aberrant anaplastic lymphoma kinase expression in high-grade pulmonary neuroendocrine carcinoma.
    Nakamura H; Tsuta K; Yoshida A; Shibata T; Wakai S; Asamura H; Furuta K; Tsuda H
    J Clin Pathol; 2013 Aug; 66(8):705-7. PubMed ID: 23618692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas.
    Boland JM; Erdogan S; Vasmatzis G; Yang P; Tillmans LS; Johnson MR; Wang X; Peterson LM; Halling KC; Oliveira AM; Aubry MC; Yi ES
    Hum Pathol; 2009 Aug; 40(8):1152-8. PubMed ID: 19386350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discordance between anaplastic lymphoma kinase status in primary non-small-cell lung cancers and their corresponding metastases.
    Kim H; Xu X; Yoo SB; Sun PL; Jin Y; Paik JH; Choe G; Jheon S; Lee CT; Chung JH
    Histopathology; 2013 Jan; 62(2):305-14. PubMed ID: 23020707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of reverse transcription-polymerase chain reaction, immunohistochemistry, and fluorescence in situ hybridization methodologies for detection of echinoderm microtubule-associated proteinlike 4-anaplastic lymphoma kinase fusion-positive non-small cell lung carcinoma: implications for optimal clinical testing.
    Wallander ML; Geiersbach KB; Tripp SR; Layfield LJ
    Arch Pathol Lab Med; 2012 Jul; 136(7):796-803. PubMed ID: 22742552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical screening for anaplastic lymphoma kinase (ALK) rearrangement in advanced non-small cell lung cancer patients.
    Park HS; Lee JK; Kim DW; Kulig K; Kim TM; Lee SH; Jeon YK; Chung DH; Heo DS
    Lung Cancer; 2012 Aug; 77(2):288-92. PubMed ID: 22465695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiparametric molecular characterization of pulmonary sarcomatoid carcinoma reveals a nonrandom amplification of anaplastic lymphoma kinase (ALK) gene.
    Pelosi G; Gasparini P; Cavazza A; Rossi G; Graziano P; Barbareschi M; Perrone F; Barberis M; Takagi M; Kunimura T; Yamada T; Nakatani Y; Pastorino U; Scanagatta P; Sozzi G; Garassino M; De Braud F; Papotti M
    Lung Cancer; 2012 Sep; 77(3):507-14. PubMed ID: 22705117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of anaplastic lymphoma kinase in Merkel cell carcinomas.
    Filtenborg-Barnkob BE; Bzorek M
    Hum Pathol; 2013 Aug; 44(8):1656-64. PubMed ID: 23574788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ALK-1 protein expression and ALK gene rearrangements aid in the diagnosis of inflammatory myofibroblastic tumors of the female genital tract.
    Fuehrer NE; Keeney GL; Ketterling RP; Knudson RA; Bell DA
    Arch Pathol Lab Med; 2012 Jun; 136(6):623-6. PubMed ID: 22646268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer.
    Pailler E; Adam J; Barthélémy A; Oulhen M; Auger N; Valent A; Borget I; Planchard D; Taylor M; André F; Soria JC; Vielh P; Besse B; Farace F
    J Clin Oncol; 2013 Jun; 31(18):2273-81. PubMed ID: 23669222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary inflammatory myofibroblastic tumor expressing a novel fusion, PPFIBP1-ALK: reappraisal of anti-ALK immunohistochemistry as a tool for novel ALK fusion identification.
    Takeuchi K; Soda M; Togashi Y; Sugawara E; Hatano S; Asaka R; Okumura S; Nakagawa K; Mano H; Ishikawa Y
    Clin Cancer Res; 2011 May; 17(10):3341-8. PubMed ID: 21430068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic implications of anaplastic lymphoma kinase gene aberrations in rhabdomyosarcoma; an immunohistochemical and fluorescence in situ hybridisation study.
    Lee JS; Lim SM; Rha SY; Roh JK; Cho YJ; Shin KH; Yang WI; Kim SH; Kim HS
    J Clin Pathol; 2014 Jan; 67(1):33-9. PubMed ID: 23922356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small non-mucinous bronchioloalveolar carcinoma with anaplastic lymphoma kinase immunoreactivity: a novel ALK fusion gene?
    Yamamoto M; Takeuchi K; Shimoji M; Maniwa T; Isaka M; Nakagawa K; Ohde Y; Kondo H; Nakajima T
    Cancer Sci; 2012 Feb; 103(2):390-2. PubMed ID: 22296236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of human achaete-scute homologue gene 1 in the gastrointestinal neuroendocrine carcinomas.
    Shida T; Furuya M; Nikaido T; Kishimoto T; Koda K; Oda K; Nakatani Y; Miyazaki M; Ishikura H
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):450-8. PubMed ID: 15701827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting anaplastic lymphoma kinase in lung cancer.
    Shaw AT; Solomon B
    Clin Cancer Res; 2011 Apr; 17(8):2081-6. PubMed ID: 21288922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification but not translocation of anaplastic lymphoma kinase is a frequent event in oesophageal cancer.
    Schoppmann SF; Streubel B; Birner P
    Eur J Cancer; 2013 May; 49(8):1876-81. PubMed ID: 23490651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rare ALK expression but no ALK rearrangement in pancreatic ductal adenocarcinoma and neuroendocrine tumors.
    Graham RP; Oliveira AM; Zhang L
    Pancreas; 2013 Aug; 42(6):949-51. PubMed ID: 23851431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of ALK expression in different human cancer types.
    Tennstedt P; Strobel G; Bölch C; Grob T; Minner S; Masser S; Simon R
    J Clin Pathol; 2014 Jun; 67(6):477-81. PubMed ID: 24478382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive histologic analysis of ALK-rearranged lung carcinomas.
    Yoshida A; Tsuta K; Nakamura H; Kohno T; Takahashi F; Asamura H; Sekine I; Fukayama M; Shibata T; Furuta K; Tsuda H
    Am J Surg Pathol; 2011 Aug; 35(8):1226-34. PubMed ID: 21753699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analyses of overall survival in patients with anaplastic lymphoma kinase-positive and matched wild-type advanced nonsmall cell lung cancer.
    Lee JK; Park HS; Kim DW; Kulig K; Kim TM; Lee SH; Jeon YK; Chung DH; Heo DS; Kim WH; Bang YJ
    Cancer; 2012 Jul; 118(14):3579-86. PubMed ID: 22086654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum.
    Falini B; Bigerna B; Fizzotti M; Pulford K; Pileri SA; Delsol G; Carbone A; Paulli M; Magrini U; Menestrina F; Giardini R; Pilotti S; Mezzelani A; Ugolini B; Billi M; Pucciarini A; Pacini R; Pelicci PG; Flenghi L
    Am J Pathol; 1998 Sep; 153(3):875-86. PubMed ID: 9736036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.